1 / 18

Adding Years To Life & Life To Years....

BDR Pharmaceuticals Int’l Pvt. Ltd. Adding Years To Life & Life To Years. BDR Pharmaceuticals Int’l Pvt. Ltd. Vision. To become strategic innovator & enhance society by endow with innovative products & medical services at affordable prices in life saving category.

Rita
Télécharger la présentation

Adding Years To Life & Life To Years....

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BDR Pharmaceuticals Int’l Pvt. Ltd. Adding Years To Life & Life To Years....

  2. BDR Pharmaceuticals Int’l Pvt. Ltd. Vision To become strategic innovator & enhance society by endow with innovative products & medical services at affordable prices in life saving category.

  3. BDR Pharmaceuticals Int’l Pvt. Ltd. Mission Early identification of newer molecules for life threatening disease that leads us to advance development & introduction of products through the strength of backward integration of developing & manufacturing API’s to facilitate Humankinds.

  4. BDR Pharmaceuticals Int’l Pvt. Ltd. • BDR Pharma has reached excellence in development & marketing • of newer APIs & Formulations. • Core strength lies in identification of newer molecules, development • and commercialization. • BDR offers widest range of finish formulations like : • Lyophilized injectables • Pegylated Liposomal & Oncology products • Gynecology and Higher range Antibiotics

  5. GROWTH MAP • Established in year 2003. • Diversified into API manufacturing in 2005 and consolidated position • in domestic market for the API Business. • Leading Niche specialty player in domestic formulation business from year 2006. • Expanded to have two API facilities at Gujarat and 2 formulation • facilities at Gujarat and Uttarakhand. • Commencing of World class, state of art F & D centre and formulation • manufacturing facility with an aim to augment our presence in the • growing global Oncology Market.

  6. GROWTH MAP

  7. ACQUISITION & JV’S

  8. STRATEGIC ROADMAP • Focusing on Non-Infringing process preparation of DMF’s as per ICH, US FDA • guidelines with respect to API. • Backward integration of manufacturing API leads to command on price advantage • Developing and concentrating on High growth therapy areas like Oncology, • Gynecology, Cardiology, High end antibiotics. • Successfully launched products like Edaravone, Citicoline , Bivalirudin, • Bortezomib, Pemetrexed, Gefitinib , Pegylated Liposomal Doxorubicin…..etc.

  9. INNOVATION IN TECHNOLOGIES • New APIs and new process design and development • New catalysts and applications • Stereo-and region-specific reactions by employing immobilized • reagents and catalysts • Semi-synthetic APIs • Industrial chromatography design and application • Process patents underway: Telmisartan, Etoricoxib, Iron Sucrose, • Ranolazine, Adapalene, Nebivolol.

  10. MARKET PRESENCE • One of the Leading Domestic player for Finish Formulation and API’s. • Global Market reach extended beyond 80 countries • Direct presence in Global markets like : Brazil, Argentina, Cuba, DR, Russia, • Sri Lanka and South East Asia etc…. • More then 40 products under registration globally and another 20 in pipeline. • Key partnership with few of the largest API players in Latin America, • South East Asia and CIS for contract manufacturing and licensing.

  11. MANUFACTURING CAPABILITIES • API Manufacturing facilities : Surat and Baroda • 2 Facilities manufactures several APIs in various segments such as NSAIDs, • Antibacterial, Antihypertensives, Cardiac care, Antiosteoperetics, Antiepileptics, • Hematinic, Antihyperlipoproteinemics besides a few others. • Finished Formulation Facilities : Surendranagar and Dehradun • 2 facilities covering Tablets, Capsules, Injectables, Oinments, Syrups.

  12. REGULATORY STATUS • Concurrent up gradation for finished formulation facilities to get MCC (South Africa), • MHRA (UK ), TGA (Australia) and US FDA. • Expertise in compilation of dossiers in CTD formats. • DMF Available for various API’s.

  13. MARKETING ALLIANCE • Product Licensing with long term supply agreements • Distribution and Marketing Tie-ups for Niche products • Technology transfer arrangements • Development of CTD Dossiers

  14. API – EXPERTISE IN HANDLING REACTION • FRIEDAL-CRAFT ACYLATION / ALKYLATION • OXIDATIONS (H2O2 / Cr2O3 / DICHROMATE) • BROMINATION • ANNULATION • HYDROLYSIS • CONDENSATION (ALKYLATION) • CRYSCOPIC REACTION ( - 80°C) • AMINATION • GRIGNARD REACTION • .

  15. API – EXPERTISE IN HANDLING REACTION • SULPHONYL CHLORINATION • ALKYLATIONS • REDUCTIONS / PRESSURE HYDROGENATION • NITRATION • ACETYLATION • HYDRO BROMINATION • HYDRO CHLORINATION • N-BUTYL LITHIUM REACTIONS • Na-METAL REACTION • .

  16. API – AVAILABLE • BASE CATALYSED ALKYLATION • PRESSURE RECTIONS (MAXIMUM UP TO 10 Kg/cm2) • DIAZOTISATION • CYNATION • AZIDE FORMATION • DEBENZYLATION • ESTERIFICATION • DIARYL COUPLING • DECARBOXYLATION • SWERN OXIDATION • CHIRAL SEPARATION • COLUMN CHROMATOGRAPHIC SEPARATION (INDUSTRIAL SCALE) • .

  17. OVERSEAS TIE-UP & CORPORATE OFFICE • . • Delta Biotech, Argentina : Prostaglandins, Deltanoids • Amega Biotech, Argentina : Anti Cancer and Life saving products. Corporate HQ: BDR Pharmaceuticals International PVT. LTD. 407/408 Sharda Chambers, 15 New Marine lines, Mumbai-400020. India Telephone: 0091-22-40560560 (30 Lines) Fax: 0091-22-40560555 Regional Office: Surat / Baroda / Ahmadabad

More Related